Plavix (R) (clopidigrel biphosphate) is a registered trademark of Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.
Contact:
For Quest Diagnostics: Kathleen Valentine (Investors), +1-973-520-2900, or Gary Samuels and Wendy Bost, (Media), +1-973-520-2800
Quest Diagnostics Incorporated and Subsidiaries
Consolidated Statements of Operations
For the Three and Nine Months Ended September 30, 2009 and 2008
(in millions, except per share and percentage data)
(unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
------------- -------------
2009 2008 2009 2008
---- ---- ---- ----
Net revenues $1,897.2 $1,826.6 $5,607.0 $5,449.1
Operating costs and expenses:
Cost of services 1,097.5 1,073.1 3,251.2 3,215.2
Selling, general and
administrative 441.6 428.2 1,314.7 1,301.3
Amortization of intangible
assets 9.2 8.8 27.6 28.0
Other operating expense
(income), net 0.6 (0.4) (15.2) (0.7)
--- ----- ------ -----
Total operating costs and
expenses 1,548.9 1,509.7 4,578.3 4,543.8
------- ------- ------- -------
Operating income 348.3 316.9 1,028.7 905.3
'/>"/>
| SOURCE Quest Diagnostics Incorporated Copyright©2009 PR Newswire. All rights reserved |